Last reviewed · How we verify
NCT06622551
Different Efficacy of IFA Supplementation Among Obese and Non-obese Women
NA trial testing Iron-folic acid supplement in Obesity and Overweight in 165 participants. Enrolling by invitation.
31 December 2024
Quick facts
| Lead sponsor | Griffith University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 165 |
| Start date | 1 August 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 30 January 2025 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Iron-folic acid supplement — full drug profile →
Conditions studied
- Obesity and Overweight — all drugs for Obesity and Overweight →
- Anemia, Iron-Deficiency — all drugs for Anemia, Iron-Deficiency →
Sponsor
Griffith University
Who can join
Adults 20 to 29, female only, with Obesity and Overweight or Anemia, Iron-Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to learn if there is a relationship between OWT/OB and IDA in nonpregnant women of reproductive age and its impact on iron supplementation. The main questions it aims to answer are: * Is there any independent association between overweight/obesity and iron deficiency anemia in nonpregnant women after controlling for potential confounding factors? * Does the effect of iron supplementation on iron status vary between overweight/obese and normal-weight nonpregnant women (as measured by multiple iron biomarkers)? Researchers will compare several biomarkers between the case and control groups after the intervention is given for 90 days. Participants will: * Visit the research center before the intervention given and after 90 days * Take daily iron-folic acid supplements for 90 days * Keep a diary of their supplement's intake
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06622551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity and Overweight
Currently open trials in the same condition.
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07032545 — Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
- NCT06935838 — Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV · Phase 2 · recruiting
Other Griffith University trials
Trials by the same sponsor.
- NCT07186361 — Symptom Assessment And Management For Adults With CKD In Vietnam · NA · not yet recruiting
- NCT06927141 — Effect of Flexible Catheter Materials on Catheter Angle and Blood Vessel Irritation · NA · completed
- NCT06993753 — Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06622551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Griffith University
- Last refreshed: 2 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06622551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing